Gallium scanning in differentiating malignant from benign asbestos-related pleural disease
In order to assess the utility of 67gallium citrate in delineating malignant pleural mesothelioma from benign asbestos-related pleural disease, 49 patients with malignant mesothelioma and 16 with benign asbestos-related pleural disease were studied. Seven patients with malignant mesothelioma had no history of asbestos exposure, while the remaining 58 patients were exposed. Forty-three of the 49 patients (88%) with malignant mesothelioma had a positive 67gallium scan including 36 of the 42 (86%) patients with asbestos exposure and all 7 patients without a history of asbestos exposure. Three of 16 patients (19%) with benign asbestos-related pleural disease had a positive scan. 67Gallium radionuclide imaging is nonspecific but may be valuable in noninvasive monitoring of asbestos-exposed populations, which have a high risk for the late development of benign and/or malignant pleural disease.
- Research Organization:
- Mount Sinai Medical Center, New York, NY
- OSTI ID:
- 5324093
- Journal Information:
- Am. J. Ind. Med.; (United States), Vol. 5
- Country of Publication:
- United States
- Language:
- English
Similar Records
Evaluation of the pleural malignant mesothelioma patients with the relation of asbestos exposure
Lymphoid and plasma cell malignancies: asbestos-related disorders of long latency
Related Subjects
62 RADIOLOGY AND NUCLEAR MEDICINE
ASBESTOS
HEALTH HAZARDS
LUNGS
SCINTISCANNING
RESPIRATORY SYSTEM DISEASES
DIAGNOSIS
CARCINOMAS
GALLIUM 67
PATIENTS
BETA DECAY RADIOISOTOPES
BODY
COUNTING TECHNIQUES
DAYS LIVING RADIOISOTOPES
DIAGNOSTIC TECHNIQUES
DISEASES
ELECTRON CAPTURE RADIOISOTOPES
GALLIUM ISOTOPES
HAZARDS
INTERMEDIATE MASS NUCLEI
ISOTOPES
NEOPLASMS
NUCLEI
ODD-EVEN NUCLEI
ORGANS
RADIOISOTOPE SCANNING
RADIOISOTOPES
RESPIRATORY SYSTEM
560306* - Chemicals Metabolism & Toxicology- Man- (-1987)
550601 - Medicine- Unsealed Radionuclides in Diagnostics